Marc D Beer

CIK 1314575 · Executive Chairman · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$377.9K

Companies

5

Total Filings

42

Lifetime Open-Market Net

-$9.71M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BTMD Executive Chairman 107,794 $2.46 $265.2K $417.2K 5 2026-06-10
biote Corp. (BTMDW) Delisted Director 2,967,092 $1.61 $4.78M -$2.60M 5 2023-05-19
NERV Director 25,000 $4.51 $112.8K $405.8K 7 2018-02-02
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Chief Executive Officer 78,831 -$7.94M 22 2015-04-03
VIACELL INC (VIAC) Delisted President & CEO 600,000 $29.58 $17.75M $0 2 2007-11-08

Recent Filings · Page 4 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-03-23 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +1,000 $14.0K EDGAR
2012-02-09 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Grant (A) $0 EDGAR
2011-09-06 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +6,754 $99.6K EDGAR
2011-08-10 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +10,065 $120.3K EDGAR
2011-08-03 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +6,330 $99.6K EDGAR
2011-06-29 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) −64,516 -$1000.0K EDGAR
2011-06-03 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Mixed +5,332 $99.7K EDGAR
2011-04-05 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +5,957 $99.7K EDGAR
2010-12-17 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +200 $2.5K EDGAR
2010-10-27 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Buy (P) +105,263 $1000.0K EDGAR
Showing 3140 of 42
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.